LGL Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198K Sell
10,145
-40,000
-80% -$794K 0.07% 61
2026
Q1
$964K Buy
+50,145
New +$988K 0.4% 26

Other funds holding SBRA

LGL Partners's SBRA Position: Q2 2026 in Review

LGL Partners reduced its Sabra Healthcare REIT (SBRA) stake by 80% in Q2 2026, selling an estimated $794K and leaving 10,145 shares worth $198K. The position accounts for 0.07% of the portfolio, ranked #61.

LGL Partners first reported a position in SBRA in Q1 2026 and has held it in 2 quarters since. The position peaked at $964K in Q1 2026. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • LGL Partners held 10,145 shares of Sabra Healthcare REIT worth $198K as of Q2 2026.
  • LGL Partners sold 40,000 Sabra Healthcare REIT shares in Q2 2026, an estimated $794K.
  • Sabra Healthcare REIT made up 0.07% of LGL Partners's portfolio in Q2 2026, its #61 holding.
  • LGL Partners first reported a position in Sabra Healthcare REIT in Q1 2026 and has held it in 2 quarters since.
  • LGL Partners's Sabra Healthcare REIT position peaked at $964K in Q1 2026.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.